Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience

BACKGROUND: Diabetic nephropathy (DN) is a complication of chronic hyperglycemia associated with diabetes mellitus (DM). Several studies have demonstrated the positive impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors on kidney outcomes. The objective of the study was to evaluate the effec...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mohammed H Tawhari, Raed A Aldahash, Faisal M Almutairi, Mahdi S Albogami, Ahmad E Rokon, Faisal A Alsomali, Khaled H Alanazi, Abdulrahman A Alshehri, Talal H Almutairi, Abdulrahman D Alharbi, Rayan M Alghamdi, Ibrahim H Tawhari, Salih A Bin Salih
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2023-01-01
Serie:	Journal of Family and Community Medicine
Soggetti:	dapagliflozin diabetic kidney disease diabetic nephropathy sodium-glucose cotransporter-2 inhibitors type 2 diabetes
Accesso online:	http://www.jfcmonline.com/article.asp?issn=2230-8229;year=2023;volume=30;issue=4;spage=267;epage=272;aulast=Tawhari
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!